Protective effect of HLA-DRB1∗13 alleles during specific phases in the development of ACPA-positive RA

Annals of the Rheumatic Diseases

Volumn 75, Issue 10, 2016, Pages 1891-1898

  Van Heemst, Jurgen ^a   Hensvold, Aase H ^b   Jiang, Xia ^b   Van Steenbergen, Hanna ^a   Klareskog, Lars ^b   Huizinga, Tom W J ^a   Van Der Helm van Mil, Annette ^a   Catrina, Anca I ^b   Toes, René E M ^a   Lundberg, Karin ^b   Van Der Woude, Diane ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DISEASE MODIFYING ANTIRHEUMATIC DRUG; EPITOPE; HLA DRB1 ANTIGEN; ANTIBODY; CYCLIC CITRULLINATED PEPTIDE; CYCLOPEPTIDE; HLA-DRB1*13 ANTIGEN;

ADULT; ALLELE; ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG WITHDRAWAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REMISSION; RHEUMATOID ARTHRITIS; SWEDISH CITIZEN; TWINS; BLOOD; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; IMMUNOLOGY; PROTECTION; REGISTER;

ADULT; ALLELES; ANTIBODIES; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; DISEASES IN TWINS; EPITOPES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-DRB1 CHAINS; HUMANS; MALE; PEPTIDES, CYCLIC; PROTECTIVE FACTORS; REGISTRIES;

EID: 84954285324     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2015-207802     Document Type: Article

References (36)

1. Viatte S, Plant D, Raychaudhuri S. Genetics, and epigenetics of rheumatoid arthritis. Nat Rev Rheumatol 2013; 9: 141-53
2. Stastny P. Mixed lymphocyte cultures in rheumatoid arthritis. J Clin Invest 1976; 57: 1148-57
3. Lundstrom E, Kallberg H, Smolnikova M, et al. Opposing effects of HLA-DRB1∗13 alleles on the risk of developing anti-citrullinated protein antibody-positive, and anti-citrullinated protein antibody-negative rheumatoid arthritis. Arthritis Rheum 2009; 60: 924-30
4. Oka S, Furukawa H, Kawasaki A, et al. Protective effect of the HLA-DRB1∗13: 02 allele in Japanese rheumatoid arthritis patients. PLoS One 2014; 9: e99453
5. Van Der Woude D, Lie BA, Lundstrom E, et al. Protection against anti-citrullinated protein antibody-positive rheumatoid arthritis is predominantly associated with HLA-DRB1∗1301: a meta-analysis of HLA-DRB1 associations with anti-citrullinated protein antibody-positive, and anti-citrullinated protein antibody-negative rheumatoid arthritis in four European populations. Arthritis Rheum 2010; 62: 1236-45
6. Trouw LA, Mahler M. Closing the serological gap: promising novel biomarkers for the early diagnosis of rheumatoid arthritis. Autoimmun Rev 2012; 12: 318-22
7. Schellekens GA, de Jong BA, Van Den Hoogen FH, et al. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 1998; 101: 273-81
8. Vossenaar ER, Despres N, Lapointe E, et al. Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin. Arthritis Res Ther 2004; 6: R142-50
9. Rantapaa-Dahlqvist S, de Jong BA, Berglin E, et al. Antibodies against cyclic citrullinated peptide, and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003; 48: 2741-9
10. Nielen MM, van Schaardenburg D, Reesink HW, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004; 50: 380-6
11. van Gaalen FA, Linn-Rasker SP, van Venrooij WJ, et al. Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis Rheum 2004; 50: 709-15
12. Willemze A, Trouw LA, Toes RE, et al. The influence of ACPA status, and characteristics on the course of RA. Nat Rev Rheumatol 2012; 8: 144-52
13. Van Der Helm-van Mil AH, Verpoort KN, Breedveld FC, et al. Antibodies to citrullinated proteins, and differences in clinical progression of rheumatoid arthritis. Arthritis Res Ther 2005; 7: R949-58
14. Van Der Helm-van Mil AH, Verpoort KN, Breedveld FC, et al. The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies, and are not an independent risk factor for development of rheumatoid arthritis. Arthritis Rheum 2006; 54: 1117-21
15. Huizinga TW, Amos CI, Van Der Helm-van Mil AH, et al. Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins. Arthritis Rheum 2005; 52: 3433-8
16. Bos WH, Ursum J, de Vries N, et al. The role of shared epitope in arthralgia with anti-cyclic citrullinated peptide antibodies (anti-CCP), and its effect on anti-CCP levels. Ann Rheum Dis 2008; 67: 1347-50
17. Hensvold HA, Magnusson PK, Joshua V, et al. Environmental, and genetic factors in the development of anticitrullinated protein antibodies (ACPAs), and ACPA-positive rheumatoid arthritis: an epidemiological investigation in twins. Ann Rheum Dis 2015; 74: 375-80
18. Verpoort KN, Cheung K, Ioan-Facsinay A, et al. Fine specificity of the anti-citrullinated protein antibody response is influenced by the shared epitope alleles. Arthritis Rheum 2007; 56: 3949-52
19. Lundberg K, Kinloch A, Fisher BA, et al. Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis, and cross-react with bacterial enolase. Arthritis Rheum 2008; 58: 3009-19
20. Lundberg K, Bengtsson C, Kharlamova N, et al. Genetic, and environmental determinants for disease risk in subsets of rheumatoid arthritis defined by the anticitrullinated protein/peptide antibody fine specificity profile. Ann Rheum Dis 2013; 72: 652-8
21. Van Der Woude D, Alemayehu WG, Verduijn W, et al. Gene-environment interaction influences the reactivity of autoantibodies to citrullinated antigens in rheumatoid arthritis. Nat Genet 2010; 42: 814-16
22. Mahdi H, Fisher BA, Kallberg H, et al. Specific interaction between genotype, smoking, and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis. Nat Genet 2009; 41: 1319-24
23. Scherer HU, Van Der Woude D, Willemze A, et al. Distinct ACPA fine specificities, formed under the influence of HLA shared epitope alleles, have no effect on radiographic joint damage in rheumatoid arthritis. Ann Rheum Dis 2011; 70: 1461-4
24. Lichtenstein P, Sullivan PF, Cnattingius S, et al. The Swedish Twin Registry in the third millennium: an update. Twin Res Hum Genet 2006; 9: 875-82
25. Magnusson PK, Almqvist C, Rahman I, et al. The Swedish Twin Registry: establishment of a biobank, and other recent developments. Twin Res Hum Genet 2013; 16: 317-29
26. Klareskog L, Stolt P, Lundberg K, et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006; 54: 38-46
27. van Aken J, van Bilsen JH, Allaart CF, et al. The Leiden Early Arthritis Clinic. Clin Exp Rheumatol 2003; 21: S100-5
28. de Rooy DP, Van Der Linden MP, Knevel R, et al. Predicting arthritis outcomes-what can be learned from the Leiden Early Arthritis Clinic? Rheumatology (Oxford) 2011; 50: 93-100
29. Knevel R, Tsonaka R, Le Cessie S, et al. Comparison of methodologies for analysing the progression of joint destruction in rheumatoid arthritis. Scan J Rheumatol 2013; 42: 182-9
30. Van Der Helm-van Mil AH, Huizinga TW, Schreuder GM, et al. An independent role of protective HLA class II alleles in rheumatoid arthritis severity, and susceptibility. Arthritis Rheum 2005; 52: 2637-44
31. Van Der Woude D, Young A, Jayakumar K, et al. Prevalence of, and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts. Arthritis Rheum 2009; 60: 2262-71
32. van Nies JA, Van Der Helm-van Mil AH. Is early remission associated with improved survival or is arthritis persistency associated with increased mortality in early arthritis? Comparisons with the general population. Ann Rheum Dis 2013; 72: e25
33. Terao C, Ohmura K, Ikari K, et al. Effects of smoking, and shared epitope on the production of anti-citrullinated peptide antibody in a Japanese adult population. Arthritis Care Res (Hoboken) 2014; 66: 1818-27
34. Feitsma AL, Worthington J, Van Der Helm-van Mil AH, et al. Protective effect of noninherited maternal HLA-DR antigens on rheumatoid arthritis development. Proc Natl Acad Sci USA 2007; 104: 19966-70
35. van Heemst J, Jansen DTSL, Moustakas AK, et al. Crossreactivity to vinculin, and microbes provides a molecular basis for HLA-based protection against rheumatoid arthritis. Nat Commun 2015; 6: 6681
36. Raychaudhuri S, Sandor C, Stahl EA, et al. Five amino acids in three HLA proteins explain most of the association between MHC, and seropositive rheumatoid arthritis. Nat Genet 2012; 44: 291-6